Ariana Pharma Collaborates With Fovea Pharmaceuticals On Phase II Clinical Data Analysis
2/4/2010 3:16:49 PM
More...
|
Sanofi-Aventis (France) (SASY.PA) to Buy Dyax Corp. (DYAX)'s (JOBS) Drug Development Partner, Fovea Pharmaceuticals
10/13/2009 6:50:52 AM
More...
|
CombinatoRx, Incorporated (CRXX)-Derived Combination Drug Candidate, Prednisporin, Acquired by Sanofi-Aventis K.K. Through Proposed Acquisition of Fovea Pharmaceuticals
10/5/2009 9:58:57 AM
More...
|
Fovea Pharmaceuticals to be Acquired by Sanofi-Aventis (France) (SASY.PA) for up to $541 Million
10/1/2009 6:49:43 AM
More...
|
Fovea Pharmaceuticals Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis
5/4/2009 11:19:19 AM
More...
|
CombinatoRx, Incorporated (CRXX) Collaborator Fovea Pharmaceuticals Reports Encouraging Clinical Results with CombinatoRx-Derived Combination Drug Candidate
5/4/2009 9:49:21 AM
More...
|
Dyax Corp. (DYAX) (JOBS) and Fovea Pharmaceuticals Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
2/10/2009 6:53:09 AM
More...
|
Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
1/7/2008 10:09:01 AM
More...
|
Fovea Pharmaceuticals Completes EUR30M Series B Financing
12/12/2007 6:37:01 AM
More...
|
Fovea Pharmaceuticals Enter Into a Research Collaboration in Ophthalmology With Genzyme Corporation (GENZ)
11/27/2007 7:16:11 AM
More...
|
|